These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 19752338
1. Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial. Sestak I, Sapunar F, Cuzick J. J Clin Oncol; 2009 Oct 20; 27(30):4961-5. PubMed ID: 19752338 [Abstract] [Full Text] [Related]
2. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. Breast International Group (BIG) 1-98 Collaborative GroupSenology Center of Eastern Switzerland, Kantonsspital, St. Gallen, and the Swiss Group for Clinical Cancer Research, Switzerland., Thürlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardley A, Price KN, Goldhirsch A. N Engl J Med; 2005 Dec 29; 353(26):2747-57. PubMed ID: 16382061 [Abstract] [Full Text] [Related]
3. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A. J Clin Oncol; 2007 Feb 10; 25(5):486-92. PubMed ID: 17200148 [Abstract] [Full Text] [Related]
4. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE. Am J Manag Care; 2006 Jul 10; 12(7):374-86. PubMed ID: 16834524 [Abstract] [Full Text] [Related]
5. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T, ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Cancer; 2003 Nov 01; 98(9):1802-10. PubMed ID: 14584060 [Abstract] [Full Text] [Related]
6. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature. Lycette JL, Luoh SW, Beer TM, Deloughery TG. Breast Cancer Res Treat; 2006 Oct 01; 99(3):249-55. PubMed ID: 16752073 [Abstract] [Full Text] [Related]
7. Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer. Nishihori T, Choi J, DiGiovanna MP, Thomson JG, Kohler PC, McGurn J, Chung GG. Clin Breast Cancer; 2008 Aug 01; 8(4):362-5. PubMed ID: 18757265 [Abstract] [Full Text] [Related]
9. Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial. Spagnolo F, Sestak I, Howell A, Forbes JF, Cuzick J. J Clin Oncol; 2016 Jan 10; 34(2):139-43. PubMed ID: 26598748 [Abstract] [Full Text] [Related]
11. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. Bundred NJ, Campbell ID, Davidson N, DeBoer RH, Eidtmann H, Monnier A, Neven P, von Minckwitz G, Miller JC, Schenk NL, Coleman RE. Cancer; 2008 Mar 01; 112(5):1001-10. PubMed ID: 18205185 [Abstract] [Full Text] [Related]
12. Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data. Buzdar AU, Cuzick J. Clin Cancer Res; 2006 Feb 01; 12(3 Pt 2):1037s-1048s. PubMed ID: 16467122 [Abstract] [Full Text] [Related]
13. Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230). Eastell R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE, ATAC Trialists' group. J Bone Miner Res; 2006 Aug 01; 21(8):1215-23. PubMed ID: 16869719 [Abstract] [Full Text] [Related]
14. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen. Carpenter R. Eur J Surg Oncol; 2008 Jul 01; 34(7):746-55. PubMed ID: 18296017 [Abstract] [Full Text] [Related]
15. Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer. Dowsett M, Pfister C, Johnston SR, Miles DW, Houston SJ, Verbeek JA, Gundacker H, Sioufi A, Smith IE. Clin Cancer Res; 1999 Sep 01; 5(9):2338-43. PubMed ID: 10499602 [Abstract] [Full Text] [Related]
16. Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome. Laroche M, Borg S, Lassoued S, De Lafontan B, Roché H. J Rheumatol; 2007 Nov 01; 34(11):2259-63. PubMed ID: 17937464 [Abstract] [Full Text] [Related]
19. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women. Mouridsen HT. Curr Med Res Opin; 2006 Aug 01; 22(8):1609-21. PubMed ID: 16870085 [Abstract] [Full Text] [Related]
20. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer]. Tuxen MK, Nielsen DL, Lindberg H, Kamby C. Ugeskr Laeger; 2007 Jan 22; 169(4):297-9. PubMed ID: 17274922 [Abstract] [Full Text] [Related] Page: [Next] [New Search]